Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 2 art units • 2 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Spiral Therapeutics Inc. is currently managing 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 4 pending office actions are distributed among 2 distinct examiners, which indicates that the company interacts with a small group of patent officials. This distribution means that the company prosecution experience is concentrated under a limited number of individual perspectives.
The busiest examiner for this portfolio is HELM, CARALYNNE E, who is responsible for 3 pending office actions. This individual workload represents a significant portion of the 4 pending office actions total. The reliance on 2 distinct examiners suggests that the company must maintain a focused prosecution strategy to address the specific requirements of these patent officials.
The involvement of 2 distinct art units means that the technical review is conducted across different specialized groups at the patent office. With 4 pending office actions and 2 distinct art units, the company must navigate various procedural preferences and technical standards. The company must tailor its responses to the specific requirements of the 2 distinct art units involved in the prosecution of these cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| Double-patenting + other | 2 (50%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 3 | 28.9% | +49.6% |
| LABRANCHE, BROOKE N | 1 | 72.7% | +15.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19463990 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
| 19459988 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
| 17923945 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18417612 | DEVICES, SYSTEMS, AND METHODS FOR TREATING EAR DISORDERS | LABRANCHE, BROOKE N | 22d overdue |
| 19463990 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
| 19459988 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
| 17923945 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | — |
| Art Unit | Apps |
|---|---|
| 1615 | 3 |
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19463990 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | — | Pending | Jan 29, 2026 |
| 19459988 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | 1615 | §103§112DP | Final Rejection | — | Pending | Jan 26, 2026 |
| 18417612 | DEVICES, SYSTEMS, AND METHODS FOR TREATING EAR DISORDERS | LABRANCHE, BROOKE N | 3771 | §103 | Non-Final OA | 22d overdue | Pending | Jan 19, 2024 |
| 17923945 | GELLING SOLUTIONS FOR ADMINISTRATION OF COMPOUNDS TO THE INNER EAR | HELM, CARALYNNE E | 1615 | §103§112DP | Non-Final OA | — | Pending | Nov 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial